Our Services
Clear, practical support across regulatory, clinical and commercial decision-making in health and medical technology.
From early strategy through to approval, market access and investment.
Support across the full product lifecycle
We work with companies, investors and leadership teams to navigate complex regulatory, clinical and commercial challenges, providing clear input at every stage.
Regulatory
Strategy, submissions and compliance across global markets
Clinical
Evidence planning, study design and clinical delivery
Commercial
Market access, adoption and growth strategy
Our core services
-
Regulatory Affairs
Supporting regulatory strategy, submissions and approvals across global markets.
MHRA, FDA, CE marking, UKCA
MDR / IVDR compliance
Technical documentation and submission
-
Clinical Strategy
Designing clinical pathways that support approval, adoption and commercial success.
Clinical evaluation and PMCF
Trial design and evidence planning
Clinical data strategy
-
M&A Regulatory Due Diligence
Helping investors and acquirers assess regulatory risk and opportunity.
Regulatory risk assessment
Product and pipeline review
Support through acquisition and integration
-
Market Approval & Access
Supporting the route from approval to successful market entry.
NHS and payer strategy
Reimbursement and access pathways
Global launch planning
Who we support
We work with organisations at different stages of growth, from early development through to investment and scale.
Investors and private equity firms
Startups & scale-ups
SMEs and health and medical technology companies
Leadership and executive teams
KEY STATISTICS
The challenges facing health and medical technology companies
Across regulatory, clinical and commercial pathways, companies face increasing complexity. These figures highlight the scale of the challenges across the product lifecycle.
67%
of 510(k) submissions trigger an additional information request
80%
of manufacturers struggle to generate sufficient clinical evidence under MDR
89%
of investors require regulatory intelligence in due diligence
97%
of healthcare data goes unused or remains unstructured
Speak to the team
Clear, practical guidance across regulatory, clinical and commercial decisions.